Ontario Formulary
9B06E001
-
- $3.99
-
- $3.99
Publisher Description
A doctor is preparing for an upcoming meeting of the Ontario Drug Quality and Therapeutics committee. At this meeting the committee would need to make a decision about adding six new drugs to the Ontario formulary. The doctor needed to review the clinical and economic evidence on each drug in order to take a position on each at the meeting. The case introduces students to the concept of formularies and presents six representative cases for class discussion.
GENRE
Business & Personal Finance
RELEASED
2005
28 November
LANGUAGE
EN
English
LENGTH
7
Pages
PUBLISHER
Richard Ivey School of Business Foundation
SELLER
Ivey Business School Foundation
SIZE
295.8
KB
More Books Like This
Agennix AG Gets Positive Results from Talactoferrin Trial
2010
Novartis Drug Tasigna Approved in Switzerland After Fast-Track Review for Treatment of Patients with Newly Diagnosed Ph+ CML
2010
Cyclacel Reports Phase 2 Survival Data with Sapacitabine
2011
Solnyx Pharmaceuticals: The Atoxeril Clinical Trial
2005
Methylgene to Resume Development of MGCD0103 (Mocetinostat)
2009
One Third on First-Line Antiretrovirals have Serious Drug Interaction (Article 11)
2010